Read this company snapshot
Daily valuation snapshot
Quoin Pharmaceuticals, Ltd. American Depositary Shares: source evidence dated 2026-10-09.
- Daily close (USD)
- $4.5
- Market capitalization (USD)
- $9,037,879.07
- Price / earnings (TTM)
- Not reported
- Price / book
- 2.3
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research QNRX in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research QNRX in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat Netherton Syndrome; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing QNRX with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $4.5 |
| Market capitalization (USD) | $9,037,879.07 |
| Price / earnings (TTM) | Not reported |
| Price / book | 2.3 |
No matching rows. Clear the filter to see all records.
Read QNRX's valuation metrics
Company size
Quoin Pharmaceuticals, Ltd. American Depositary Shares's recorded market capitalization is $9,037,879.07. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
QNRX's recorded price-to-book ratio is 2.3. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Quoin Pharmaceuticals, Ltd. American Depositary Shares with Aurora
Use the snapshot above to ask a specific question about QNRX. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow QNRX's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.